<DOC>
	<DOCNO>NCT00495716</DOCNO>
	<brief_summary>The purpose study determine effect suppressive therapy sexual behavior quality life among person genital herpes ( HSV ) multiple sex partner .</brief_summary>
	<brief_title>Effect HSV-2 Suppressive Therapy Sexual Behavior</brief_title>
	<detailed_description>We plan conduct randomize controlled trial chronic suppressive acyclovir , 400 mg orally twice daily ( standard dose ) versus episodic acyclovir treatment genital herpes recurrence . We enroll 500 HSV-2 seropositive single person ( 250 per arm ) , stratify gender history symptomatic genital herpes , prospectively follow 1 year assess sexual behavior , adherence therapy , herpes-related quality life . These outcome measure self-report confidential , computer-based assessment . We plan use data trial model effect increase proportion sexually-active HSV-2 infected person take suppressive therapy population-level incidence prevalence HSV-2 .</detailed_description>
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Age 18 year old HSV2 seropositive Western blot OR document culture positive HSV2 anogenital site 2 vaginal anal sex partner past 12 month Not currently monogamous sexual relationship &gt; = 6 month duration Willing able randomize comply study protocol Pregnancy intention become pregnant within next year Suppressive therapy acyclovir , valacyclovir , famciclovir within 2 week enrollment/randomization 6 symptomatic herpes recurrence prior 12 month 12 month prior start suppressive therapy suppressive therapy prior 12 month HIV seropositive know immunocompromising medical condition . HIV negative test must perform within 60 day Visit 1 ( enrollment/randomization ) . For current former participant HIV vaccine clinical trial HIV vaccineinduced seropositivity potentially leading vaccine study unblinding may concern , report Seattle HVTU document participant HIV uninfected base HIV test do within 60 day Visit 1 accept lieu HIV test do clinic . Intention move Seattle area within next year Known allergy , intolerance , medical contraindication acyclovir Inability understand , speak , read English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>